Holen Sie sich die Stockscreener-App
0.608
1.33%
0.008
Equillium Inc Aktie (EQ) Neueste Nachrichten
Equillium stock touches 52-week low at $0.6 amid market challenges - Investing.com Australia
Equillium Announces Board and Audit Committee Changes - TipRanks
Contrasting CSL (OTCMKTS:CSLLY) and Equillium (NASDAQ:EQ) - Defense World
Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge - Simply Wall St
Equillium CFO Jason Keyes sells $7,000 in stock By Investing.com - Investing.com Nigeria
Equillium CFO Jason Keyes sells $7,000 in stock - Investing.com
Equillium’s Q3 Financials and Clinical Progress in Focus - TipRanks
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates - The Bakersfield Californian
Equillium to Present at the Stifel Healthcare Conference - The Bakersfield Californian
Equillium to Present Clinical Pipeline Updates at Stifel Healthcare Conference | EQ Stock News - StockTitan
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer - BioSpace
Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth - MSN
Equillium keeps equilibrium in GVHD after Ono no-go - BioWorld Online
Equillium says Ono not acquiring itolizumab, stock craters 36% - MSN
Ono says no to Equillium’s itolizumab - The Pharma Letter
Jones Trading Downgrades Equillium (EQ) - MSN
Equillium retains rights to itolizumab after Ono's option expires - Investing.com India
Equillium shares downgraded to hold from buy By Investing.com - Investing.com Canada
Equillium shares downgraded to hold from buy - Investing.com India
Equillium says Ono not acquiring itolizumab, stock craters 36% (NASDAQ:EQ) - Seeking Alpha
Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire
Equillium COO Christine Zedelmayer sells $18,750 in stock - Investing.com
Equillium COO Christine Zedelmayer sells $18,750 in stock By Investing.com - Investing.com Australia
Insider Sale: Sr. Vice President and COO Christine Zedelmayer Se - GuruFocus.com
Alto Ingredients And 2 Other US Penny Stocks To Watch Closely - Simply Wall St
Moleculin Biotech (NASDAQ:MBRX) versus Equillium (NASDAQ:EQ) Financial Comparison - Defense World
Renaissance Technologies LLC Acquires 91,200 Shares of Equillium, Inc. (NASDAQ:EQ) - Defense World
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer - StockTitan
Equillium CFO Jason Keyes sells $8,100 in company stock By Investing.com - Investing.com South Africa
Equillium CFO Jason Keyes sells $8,100 in company stock - Investing.com India
Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop - Simply Wall St
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Equillium executive sells $32,985 in stock - Investing.com India
Equillium executive sells $32,985 in stock By Investing.com - Investing.com Australia
Equillium collaborates with Vivtex for oral formulation of autoimmune therapy - Yahoo Finance
Vivtex Enters New Research Agreement with Equillium to Develop GI-targeted Formulations for its First-in-Class Oral, Bi-Specific Peptide Therapy - ForexTV.com
Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit - StockTitan
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Wall Street analysts’ outlook for Equillium Inc (EQ) - SETE News
Equillium Inc’s Market Journey: Closing Weak at 1.07, Down -0.93 - The Dwinnex
How should investors view Equillium Inc (EQ)? - US Post News
Equillium Inc Inc. (EQ) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference - StockTitan
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):